P. Salvatore, P. Donda, V. Massimo - Vol. 6, Marzo 2000, num.1
Testo Bibliografia Summary Riassunto Indice
La fluoxetina nella bulimia nervosa
Fluoxetine in bulimia nervosa
Advokat C, Kutlesic V.
Pharmacotherapy of the eating disorders: A commentary.
Neurosci Biobebav Rev 1995;19:59-66.
Bretz WA, Krahn DD, Drury M e Coll.
Effects of fluoxetine on the oral environment of bulimics.
Oral Microbiol Immunol 1993;8:62-64.
Brotzman A, Herzog D, Woods S.
Antidepressant treatment of bulimia: the relationship between bingeing and
depressive symptomatology.
J Clin psychiatry 1984;45:7-9.
Corcos M, Flament M, Atger F, Jeammet Ph.
Traitement pharmacologique de la boulimie.
L’Encéphale 1996;XXII:133-142.
Fava M, Abrabam M, Clancy-Colecchi K, Pava JA, Matthews J, Rosenbaum JF.
Eating disorder symptomatology in major depression.
J Nerv Ment Dis 1997;185:140-144.
Fichter MM, Leibl K, Rief W, e Coll.
Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing
intensive psychotherapy.
Pharmacopsychiatry 1991;24:1-7.
Fluoxetine Bulimia Nervosa Collaborative Study Group.
Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled,
double-blind trial.
Arch Gen Psychiatry 1992;49:139-147.
Goldbloom DS, Olmsted MP.
Pharmacotherapy of bulimia nervosa with fiuoxetine: Assessment of clinically
significant attitudinal change.
Am J Psychiatry 1993;150:770-774.
Goldstein DJ, Wilson MG, Thompson VL and the Fluoxetine Bulimia Nervosa Research
Group.
Long-term fluoxetine treatment of Bulimia Nervosa.
Br J Psychiatry 1995;166:660-666.
Horne RL, Ferguson JM, Pope HG, Hudson JI, Lineberry CG, Ascher J, Cato A.
Treatment of bulimia with bupropion: a multicenter controlled trial.
J Clin Psychiatry 1988;49:262-266.
Hughes PL, Wells LA, Cunningham CJ, Ilstrup DM.
Treating bulimia with desipramine.
Arch Gen Psychiatry 1986;43:182-186.
Jimerson DC, Lesem MD, Kaye WH, Brewerton TD.
Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid
from bulimic patients with frequent binge episodes.
Arch Gen Psychiatry 1992;49:132-138.
Jimerson DC, Wolte BE, Metzger ED, Finkelstein DM, Cooper TB, Levine JM.
Decreased serotonin function in bulimia nervosa.
Arch Gen Psychiatry 1997;54(6):529-534.
Kaye WH, Gwirtsman HE, George DT, Weiss SR, Jimerson DC.
Relationship of mood alterations to bingeing behaviour in bulimia.
Br J Psychiatry 1986;149:479-485.
Kennedy SH, Piran N, Warsh JJ, Prendergrast P, Mainprize E, Whynot C, Garfinkel
PE.
A trial of isocarboxazid in the treatment of bulimia nervosa.
J Clin Psychopharmacol 1988;8:391-396.
Levine LR, Pope HG, Enas GG, e Coll.
Fluoxetine in the treatment of bulimia nervosa.
Arch Gen Psychiatry 1992;49:139-147.
Maser JD, Weise R, Gwirtsman H.
Depression and its boundaries with selected Axis I disorders.
In: Beckham EE, Leber WR, eds. Handbook of depression. New York: Guilford
Publications 1995:86-106.
Mitchell JE, Raymond N, Specker S.
A rewiew of the controlled trials of phannacotherapy and psychotherapy in
the treatment of bulimia nervosa.
Int J Eat Dis 1993;14:229-247.
Pope HG, Hudson Jl, Jonas JM, Yurgelun-Todd D.
Bulimia treated with imipramine: placebo-controlled, double-blind study.
Am J Psychiatry 1983;140:554-558.
Silverstone T.
The place of appetite-suppressant drugs in the treatment of obesity.
In: Stunkard AJ, Wadden TA, eds. Obesity: theory and therapy, 2nd
ed. New York: Raven Press, 1993;275-285.
Stokes PE, Holtz A.
Fluoxetine Tenth Anniversary Update: The Progress Continues.
Clin The 1997;19(5):1177-1179.
Swift WJ, Andrews D, Barklage NE.
The relationship between affective disorder and eating disorders. A review
of the literature.
Am J Psychiatry 1986;143:290-299.
Walsh BT, Gladis M, Roose SP, Stewart GW, Stetner F, Glassman AH.
Phenelzine vs placebo in 50 patients with bulimia.
Arch Gen Psychiatry 1988;45:471-475.
Walsh BT.
Psychopharmacologic treatment of bulimia nervosa.
J Clin Psychiatry 1991;52 Suppl:34-38.
Wheadon DE, Wilson MG, Rampey AH, Thompson VL.
Fluoxetine in the long-term treatment of bulimia nervosa.
Clin Res 1991;39:769A.Abstract.
Wold PN.
Eating disorder symptoms in affective disorders.
J Psychiatry Neurosci 1991;16(4):204-208.
Wood A.
Pharmacotherapy of bulimia nervosa - experience with fluoxetine.
Int Clin Psychopharmacol 1993;8:295-299.